Maine Researchers Are Working on a Test that Could Diagnose Alzheimer's Disease Decades Early
FINLAND, JUL 14 – Researchers found blood biomarkers linked to Alzheimer's in 2,051 middle-aged Finns, suggesting early detection could improve preventive care for those at risk.
- Since 2016, a team based in Bar Harbor has been developing a test that uses a combination of retinal imaging and blood analysis to identify early biomarkers indicative of Alzheimer's disease.
- This initiative responds to the need for earlier, less invasive diagnostics as evidence shows Alzheimer's processes begin decades before symptoms appear.
- A Finnish study led by Suvi Rovio found blood-based biomarkers associated with Alzheimer's in middle-aged people, highlighting new insights starting from middle age.
- Marja Heiskanen highlighted that their research sheds light on biomarker measurements and related influences beginning in middle age, underlining the importance of early indicators of disease.
- These advances may enable earlier detection and preventive treatment as USC Brain Health expands clinics in high-risk areas like Orangeburg with limited neurologists.
14 Articles
14 Articles
Fear dreams have been associated with dementia before. Now we can see what physical tribute regular nocturnal horrors can demand
Neuroimmune contributions to Alzheimer’s disease: a focus on human data
The past decade has seen the convergence of a series of new insights that arose from genetic and systems analyses of Alzheimer’s disease (AD) with a wealth of epidemiological data from a variety of fields; this resulted in renewed interest in immune responses as important, potentially causal components of AD. Here, we focus primarily on a review of human data which has recently yielded a set of robust, reproducible results that exist in a much l…
Coverage Details
Bias Distribution
- 80% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium